Try

Cencora, Inc.

CORUnited States

73 filed reports · 535 financial concepts · 42 earnings calls · 0 media appearances

Filed reports

73 reports · Jun 2016 to Jun 2026

Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 244 guidance figures.

Report typeReportsFactsPeriods
Current · 8-KSEC EDGAR32192Sep 2018 to Jun 2026
Quarterly · 10-QSEC EDGAR315,335Jun 2016 to Jun 2026
Annual · 10-KSEC EDGAR105,821Sep 2016 to Sep 2025

Documents

PeriodTypePeriod endPublishedFactsSource
FY2026 Q38-KJun 30, 2026Aug 5, 202610Open
FY2026 Q310-QJun 30, 2026Aug 5, 2026369Open
FY2026 Q28-KMar 31, 2026May 6, 20262Open
FY2026 Q210-QMar 31, 2026May 6, 2026273Open
FY2026 Q18-KDec 31, 2025Feb 4, 20262Open
FY2026 Q110-QDec 31, 2025Feb 4, 2026277Open
FY202510-KSep 30, 2025Nov 25, 2025986Open
FY2025 Q48-KSep 30, 2025Nov 5, 202512Open
FY2025 Q310-QJun 30, 2025Aug 6, 2025166Open
FY2025 Q38-KJun 30, 2025Aug 6, 20251Open
FY2025 Q28-KMar 31, 2025May 7, 20252Open
FY2025 Q210-QMar 31, 2025May 7, 2025161Open

Financial data

535 concepts · 11,348 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial492 concepts · 10,069 facts · Jan 2014 to Jul 2026

  • Unrecognized tax benefits72 · Sep 2014 to Jun 2026
  • Gross profit (US GAAP)59 · Sep 2014 to Jun 2026
  • Inventory LIFO reserve period charge59 · Sep 2014 to Jun 2026
  • Net income loss59 · Sep 2014 to Jun 2026
  • Operating income loss59 · Sep 2014 to Jun 2026
  • Revenue59 · Sep 2014 to Jun 2026
  • Amortization of intangible assets57 · Sep 2014 to Jun 2026
  • Comprehensive income net of tax57 · Sep 2014 to Jun 2026
  • Depreciation nonproduction57 · Sep 2014 to Jun 2026
  • Gain loss related to litigation settlement57 · Sep 2014 to Jun 2026
  • Income tax expense benefit57 · Sep 2014 to Jun 2026
  • Incremental common shares attributable to share based payment arrangements57 · Sep 2014 to Jun 2026
  • Interest income expense nonoperating net57 · Sep 2014 to Jun 2026
  • Nonoperating income expense57 · Sep 2014 to Jun 2026
  • Other comprehensive income loss foreign currency transaction and translation adjustment net of tax57 · Sep 2014 to Jun 2026
  • Other comprehensive income loss net of tax57 · Sep 2014 to Jun 2026
  • Other comprehensive income other net of tax57 · Sep 2014 to Jun 2026
  • Restructuring charges57 · Sep 2014 to Jun 2026
  • Selling general and administrative expense57 · Sep 2014 to Jun 2026
  • Adjustment for amortization56 · Sep 2014 to Jun 2026
  • Deferred income tax expense benefit56 · Sep 2014 to Jun 2026
  • Depreciation56 · Sep 2014 to Jun 2026
  • Goodwill (US GAAP)56 · Sep 2014 to Jun 2026
  • Increase decrease in accounts receivable56 · Sep 2014 to Jun 2026

Segment20 concepts · 1,032 facts · Sep 2014 to Jun 2026

  • Revenue342 · Sep 2014 to Jun 2026
  • Operating income loss136 · Sep 2014 to Jun 2026
  • Goodwill108 · Sep 2015 to Jun 2026
  • Goodwill foreign currency translation gain loss104 · Sep 2015 to Jun 2026
  • Goodwill acquired during period80 · Sep 2015 to Jun 2026
  • Depreciation depletion and amortization46 · Sep 2014 to Jun 2026
  • Goodwill purchase accounting adjustments32 · Dec 2018 to Jun 2026
  • Operating Income25 · Sep 2018 to Jun 2022
  • Segment expenditure addition to long lived assets24 · Sep 2021 to Jun 2026
  • Goodwill impairment loss23 · Sep 2018 to Jun 2026
  • Payments to acquire property plant and equipment22 · Sep 2014 to Sep 2022
  • Cost of goods and services sold (US GAAP)20 · Sep 2023 to Jun 2026
  • Operating expenses (US GAAP)20 · Sep 2023 to Jun 2026
  • Goodwill written off related to sale of business unit18 · Sep 2015 to Sep 2023
  • Goodwill transfers10 · Sep 2021 to Jun 2026
  • Total Assets10 · Sep 2015 to Sep 2019
  • Capital Expenditures4 · Sep 2018 to Sep 2021
  • Depreciation & Amortization4 · Sep 2018 to Sep 2021
  • Goodwill other increase decrease2 · Dec 2016
  • Operating Segments2 · Jun 2026

Guidance21 concepts · 240 facts · Nov 2018 to Aug 2026

  • EPS (Diluted) Guidance60 · Nov 2018 to Aug 2026
  • Capital Expenditures Guidance34 · Nov 2018 to Aug 2026
  • Operating Income Growth Guidance32 · Aug 2019 to Aug 2026
  • Free Cash Flow Guidance28 · Nov 2018 to Aug 2026
  • Effective Tax Rate Guidance26 · Nov 2018 to Aug 2026
  • Revenue Growth Guidance25 · May 2020 to Aug 2026
  • EPS (Diluted) Guidance (Adjusted (non-GAAP))4 · Aug 2023 to Nov 2023
  • Operating Income Growth Guidance (Adjusted (non-GAAP))4 · Aug 2023 to Nov 2023
  • Free Cash Flow Guidance (Adjusted (non-GAAP))3 · Aug 2023 to Nov 2023
  • Effective Tax Rate Guidance (Adjusted (non-GAAP))2 · Nov 2023
  • EPS (Diluted) Growth Guidance (Adjusted, constant currency)2 · Aug 2023
  • EPS (Diluted) Growth Guidance (Adjusted (non-GAAP))2 · Aug 2023
  • EPS (Diluted) Growth Guidance (excluding contributions related to COVID-19; Adjusted, constant currency)2 · Aug 2023
  • EPS (Diluted) Growth Guidance (excluding contributions related to COVID-19; Adjusted (non-GAAP))2 · Aug 2023
  • Operating Income Growth Guidance (Adjusted, constant currency)2 · Nov 2023
  • Operating Income Growth Guidance (Adjusted, constant currency, excluding COVID-19)2 · Nov 2023
  • Operating Income Growth Guidance (Adjusted, excluding COVID-19)2 · Nov 2023
  • Operating Income Growth Guidance (excluding contributions related to COVID-19; Adjusted (non-GAAP))2 · Aug 2023
  • Operating Income Guidance2 · Aug 2021
  • Revenue Growth Guidance (Constant currency)2 · Nov 2023
  • Revenue Growth Guidance (Excluding COVID-19)2 · Nov 2023

Product2 concepts · 7 facts · Sep 2016 to Sep 2020

  • Selling general and administrative expense4 · Sep 2017 to Sep 2020
  • Cost of goods and services sold (US GAAP)3 · Sep 2016 to Sep 2018

Segments

1,039 facts

Figures broken down by business line, region, product or another axis the company reports on.

Statement business segments10 members · 869 facts

  • International Healthcare Solutions207 · Sep 2020 to Jun 2026
  • US Healthcare Solutions192 · Sep 2020 to Jun 2026
  • All Other Segments143 · Sep 2014 to Sep 2021
  • Pharmaceutical Distribution143 · Sep 2014 to Sep 2021
  • All other segments68 · Sep 2015 to Sep 2021
  • International healthcare solutions37 · Dec 2020 to Jun 2026
  • Ushealthcare solutions37 · Dec 2020 to Jun 2026
  • Pharmaceutical distribution34 · Sep 2015 to Sep 2021
  • Global Commercialization Services4 · Sep 2017 to Sep 2020
  • MWI Animal Health4 · Sep 2017 to Sep 2020

Subsegments6 members · 163 facts

  • Alliance Healthcare38 · Sep 2019 to Sep 2025
  • Other Healthcare Solutions31 · Sep 2020 to Sep 2025
  • Animal Health29 · Dec 2020 to Sep 2025
  • Human Health29 · Dec 2020 to Sep 2025
  • Global Commercialization Services18 · Dec 2017 to Sep 2021
  • MWI Animal Health18 · Dec 2017 to Sep 2021

Product or service1 member · 7 facts

  • Shipping And Handling7 · Sep 2016 to Sep 2020

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

  • Earnings-release commentary100 claims from 8 reports · Sep 2024 to Jun 2026
  • Management discussion (MD&A) commentary171 claims from 8 reports · Sep 2024 to Jun 2026
  • Risk-factor changes17 claims from 1 reports · Sep 2025
  • Risk factors66 risks from 2 annual reports · 2024 to 2025

Earnings calls

42 calls · Jul 2016 to Aug 2026

Transcripts with management claims and analyst questions, one per fiscal period.

  • FY2026 Q3Aug 5, 2026
  • FY2026 Q2May 6, 2026
  • FY2026 Q1Feb 4, 2026
  • FY2025 Q4Nov 5, 2025
  • FY2025 Q3Aug 6, 2025
  • FY2025 Q2May 7, 2025
  • FY2025 Q1Feb 5, 2025
  • FY2024 Q4Nov 6, 2024
  • FY2024 Q3Jul 31, 2024
  • FY2024 Q2May 1, 2024
  • FY2024 Q1Jan 31, 2024
  • FY2023 Q4Nov 4, 2023
  • FY2023 Q3Aug 2, 2023
  • FY2023 Q2May 2, 2023
  • FY2023 Q1Feb 1, 2023
  • FY2022 Q4Nov 3, 2022

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.

Cencora, Inc. (COR) data · FactIQ